Botulinum Toxin A in Upper Limb Spasticity Management: Changing Clinical Practice. Data from the Upper Limb International Spasticity (ULIS)

被引：0
|
作者：
Turner-Stokes, Lynne [1 ]
Ashford, Stephen [1 ]
Fheodoroff, Klemens [2 ]
Jacinto, Jorge [3 ]
Brashear, Allison [4 ]
Maisonobe, Pascal [5 ]
Lysandropoulos, Andreas [6 ]
机构：
[1] Kings Coll London, Sch Med, Palliat Care Policy & Rehabil & Reg Rehabil Unit, Northwick Pk Hosp, London, England
[2] Gailtal Klin, Dept Neurorehabil, Hermagor, Austria
[3] Ctr Med Reabilitacaode Alcoitao, Serv Reabilitacao Adultos, Estoril, Portugal
[4] Wake Forest Sch Med, Dept Neurol, Winston Salem, NC USA
[5] Ipsen Pharma, Biometry, Boulogne, France
[6] Ipsen Pharma, Global Med Affairs, Boulogne, France
来源：
BRAIN INJURY | 2019年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
0508
引用
收藏
页码：191 / 192
页数：2
相关论文
共 50 条
  • [41] Contralateral Upper Limb Weakness Following Botulinum Toxin A Injection or Poststroke Spasticity
    Camoes-Barbosa, Alexandre
    Ribeiro, Ines Mendes
    Medeiros, Luisa
    ACTA MEDICA PORTUGUESA, 2020, 33 (11): : 761 - +
  • [42] The lowest effective dose of botulinum A toxin in adult patients with upper limb spasticity
    Suputtitada, A
    Suwanwela, NC
    DISABILITY AND REHABILITATION, 2005, 27 (04) : 176 - 184
  • [43] Repeated dosing of botulinum toxin type A for upper limb spasticity following stroke
    Gordon, MF
    Brashear, A
    Elovic, E
    Kassicieh, D
    Marciniak, C
    Liu, J
    Turkel, C
    NEUROLOGY, 2004, 63 (10) : 1971 - 1973
  • [44] BUDGET IMPACT ANALYSIS OF BOTULINUM TOXIN A THERAPY FOR UPPER LIMB SPASTICITY IN GERMANY
    Zoellner, Y. F.
    Gerwe, M.
    Richter, M.
    VALUE IN HEALTH, 2014, 17 (07) : A479 - A480
  • [45] Botulinum toxins in the treatment of upper and lower limb spasticity
    O'Brien, C
    OPTIMAL PATIENT MANAGEMENT WITH BOTULINUM TOXINS: EVIDENCE AND EXPERIENCE, 2002, (74): : 16 - 22
  • [46] Botulinum toxin type A use and goal attainment in real-life clinical management of post-stroke upper limb spasticity: The ULIS II project
    Faux, S.
    Aggarwal, A.
    Baguley, I. J.
    Morrison, S.
    King, C.
    Zeman, B.
    Pollack, M.
    Turner-Stokes, L.
    de Abadal, M.
    Stork, A.
    INTERNATIONAL JOURNAL OF STROKE, 2014, 9 : 3 - 3
  • [47] The profile of adult patients with upper limb muscle spasticity treated with botulinum toxin type A (an international survey)
    Khat'Kova, S. E.
    Timerbaeva, S. L.
    Orlova, O. R.
    Poznyakova, E. V.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2011, 111 (08) : 23 - 26
  • [48] The Upper Limb International Spasticity (ULIS-II) Study: UK versus global results
    Prasad, R.
    Ashford, S.
    Turner-Stokes, L.
    INTERNATIONAL JOURNAL OF STROKE, 2014, 9 : 17 - 17
  • [49] Goal Attainment with Integrated Upper Limb Spasticity Management Including Botulinum Toxin A (BoNT-A): Sub-analysis of Australian Data From the ULIS-III Study
    Luk, Edwin
    Olver, John
    Nunan, Rachael
    Baguley, Ian J.
    Estell, John
    Marinkovich, Dion
    Grandoulier, Anne-Sophie
    Turner-Stokes, Lynne
    INTERNATIONAL JOURNAL OF STROKE, 2023, 18 (02) : 45 - 46
  • [50] The role of neurectomy in the management of spasticity of the upper limb
    Mikalef, Petros
    Power, Dominic
    EFORT OPEN REVIEWS, 2017, 2 (11): : 469 - 473
12345